Press release
Masimo Reports Fourth Quarter and Full-Year 2021 Financial Results and Announces Agreement to Acquire Sound United
Fourth Quarter 2021 Highlights: Product revenue increased 11.0% to $327.6 million, GAAP net income per diluted share was $1.18; and Non-GAAP net income per
About this update from Masimo Corporation
[{"type":"text","content":"\nFourth Quarter 2021 Highlights:\n\n\nProduct revenue increased 11.0% to $327.6 million,\n\n\nGAAP net income per diluted share was $1.18; and\n\n\nNon-GAAP net income per diluted share was $1.21.\n\n\nFull-Year 2021 Highlights:\n\n\nProduct revenue increased 8.3% to $1,239.2 million,\n\n\nGAAP net income per diluted share was $3.98; and\n\n\nNon-GAAP net income per diluted share was $3.99.\n\n\n IRVINE, Calif.--(BUSINESS WIRE)--\nMasimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended January 1, 2022.\n\nFourth Quarter 2021 Results:\n\nProduct revenue increased 11.0% to $327.6 million, or 11.5% on a constant currency basis, compared to $295.1 million in the fourth quarter of 2020. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 76,000 in the fourth quarter of 2021.\n\nFor the fourth quarter 2021, GAAP operating margin was 23.6%, compared to 22.0% in the fourth quarter of 2020. Fourth quarter 2021 non-GAAP operating margin was 25.7%, compared to 23.1% in the fourth quarter of 2020.\n\nFor the fourth quarter 2021, GAAP net income was $68.3 million, or $1.18 per diluted share, compared to GAAP net income of $70.6 million or $1.21 per diluted share, in the fourth quarter 2020. Fourth quarter 2021 non-GAAP net income was $70.1 million, or $1.21 per diluted share, compared to net income of $57.3 million, or $0.98 per diluted share, in the fourth quarter 2020.\n\nFull-Year 2021 Results:\n\nProduct revenue increased 8.3% to $1,239.2 million, or 7.6% on a constant currency basis, compared to $1,143.7 million for the full-year 2020. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 289,000 for the full-year 2021.\n\nFor the full-year of 2021, GAAP operating margin was 22.3%, compared to 22.4% in the prior year period. Full-year 2021 non-GAAP operating margin was 23.8%, compared to 23.1% in the prior year period.\n\nFor the full-year of 2021, GAAP net income was $229.6 million, or $3.98 per diluted share, compared to net income of $240.3 million, or $4.14 per diluted share, in 2020. Non-GAAP net income was $230.4 million, or $3.99 per diluted share, compared to net income of $209.2 million, or $3.60 per diluted share, in 2020.\n\nJoe Kiani, Chairman and Chief Exec...